Sarepta Therapeutics (Nasdaq: SRPT) has announced it will cease development of SRP-5051, an experimental drug for Duchenne ...

Abdel Hamid Dbeibah, has agreed to prepare a national treatment program for muscular dystrophy. According to Dbeibah’s decision, which was published by the Ministry of Health on Sunday, the program is ...

Saudi researchers from Qassim University identified Bethlem Myopathy, a rare genetic disorder. The scientific discovery sheds ...